Literature for MD3 (S26.001 inhibitor)
(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)
-
Martinez-Guitian,M., Vazquez-Ucha,J.C., Odingo,J., Parish,T., Poza,M., Waite,R.D., Bou,G., Wareham,D.W. and Beceiro,A.
Synergy between colistin and the signal peptidase inhibitor MD3 is dependent on the mechanism of colistin resistance in Acinetobacter baumannii
Antimicrob Agents Chemother (2016) 60, 4375-4379. PubMed Europe PubMed DOI I -
Personne,Y., Curtis,M.A., Wareham,D.W. and Waite,R.D.
Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin
J Antimicrob Chemother (2014) 69, 3236-3243. PubMed Europe PubMed DOI I -
Ollinger,J., O'Malley,T., Ahn,J., Odingo,J. and Parish,T.
Inhibition of the sole type I signal peptidase of Mycobacterium tuberculosis is bactericidal under replicating and nonreplicating conditions
J Bacteriol (2012) 194, 2614-2619. PubMed Europe PubMed DOI I
2016
2014
2012
